Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-010145
Filing Date
2022-04-25
Accepted
2022-04-25 17:11:19
Documents
5
Period of Report
2022-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2022def14a.htm DEF 14A 591266
2 image_3.jpg GRAPHIC 283
3 image_61.jpg GRAPHIC 35798
4 proxycard1.jpg GRAPHIC 79069
5 proxycard2.jpg GRAPHIC 153601
  Complete submission text file 0001628280-22-010145.txt   945719
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38295 | Film No.: 22850574
SIC: 2836 Biological Products, (No Diagnostic Substances)